These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2688988)

  • 21. Restenosis after percutaneous transluminal coronary angioplasty.
    Foley DP; Hermans WM; Rensing BJ; de Feyter PJ; Serruys PW
    Herz; 1992 Feb; 17(1):1-17. PubMed ID: 1541446
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Restenosis after PTCA].
    Heidland UE; Michel CJ; Heintzen MP; Strauer BE
    Dtsch Med Wochenschr; 1998 Jul; 123(27):840-6. PubMed ID: 9685844
    [No Abstract]   [Full Text] [Related]  

  • 23. Influence of the methodology of percutaneous transluminal coronary angioplasty on restenosis.
    Douglas JS; King SB; Roubin GS
    Am J Cardiol; 1987 Jul; 60(3):29B-33B. PubMed ID: 2956837
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Protection against ischemic damage during percutaneous coronary angioplasty].
    Specchia G; Ghio S; Bramucci E; Angoli L; Raffaghello S; De Servi S
    Cardiologia; 1991 Dec; 36(12 Suppl 1):215-20. PubMed ID: 1688158
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Failure of diltiazem to prevent restenosis after percutaneous transluminal coronary angioplasty.
    Corcos T; David PR; Val PG; Renkin J; Dangoisse V; Rapold HG; Bourassa MG
    Am Heart J; 1985 May; 109(5 Pt 1):926-31. PubMed ID: 3158187
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Guide wire-induced coronary artery spasm during percutaneous transluminal coronary angioplasty. A case report.
    Takahashi M; Ikeda U; Sekiguchi H; Fujikawa H; Shimada K; Ri T
    Angiology; 1996 Mar; 47(3):305-9. PubMed ID: 8638877
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacologic effects of calcium channel blockers on restenosis.
    Thaulow E
    J Cardiovasc Pharmacol; 1999; 33 Suppl 2():S12-6. PubMed ID: 10071258
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of patients after coronary angioplasty.
    Popma JJ; Dehmer GJ
    Am Fam Physician; 1990 Jan; 41(1):121-9. PubMed ID: 2403720
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of calcium channel blockers in reducing acute ischaemia and preventing restenosis in PTCA.
    Vahanian A; Lung B
    Drugs; 1996; 52 Suppl 4():9-15; discussion 15-6. PubMed ID: 8913714
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Frankfurt experience in restenosis after coronary angioplasty.
    Bussmann WD; Kaltenbach M; Kober G; Vallbracht C
    Am J Cardiol; 1987 Jul; 60(3):48B-49B. PubMed ID: 2956842
    [TBL] [Abstract][Full Text] [Related]  

  • 31. On trials to avoid restenosis after PTCA.
    Hugenholtz PG
    Cardiologia; 1992 Mar; 37(3):185-7. PubMed ID: 1504961
    [No Abstract]   [Full Text] [Related]  

  • 32. Role of beta-adrenergic blockers after percutaneous transluminal coronary angioplasty.
    Johansson SR; Lamm C; Bondjers G; Emanuelsson H; Hjalmarson A
    Am J Cardiol; 1990 Oct; 66(12):915-20. PubMed ID: 1977297
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Angioplasty versus medical therapy for single-vessel coronary artery disease.
    McGivney SA
    N Engl J Med; 1992 Jun; 326(24):1632; author reply 1633-4. PubMed ID: 1584268
    [No Abstract]   [Full Text] [Related]  

  • 34. The effects of calcium antagonists after PTCA.
    Hoberg E
    Eur Heart J; 1995 Aug; 16 Suppl H():9-12. PubMed ID: 8846803
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Prevention of complications and the methods of increasing the safety of percutaneous transluminal coronary angioplasty (PTCA)].
    Dabrowski M
    Kardiol Pol; 1992 Nov; 37(11):321-6. PubMed ID: 1287296
    [No Abstract]   [Full Text] [Related]  

  • 36. Restenosis after multilesion percutaneous transluminal coronary angioplasty.
    Vandormael MG; Deligonul U; Kern MJ; Kennedy H; Galan K; Chaitman B
    Am J Cardiol; 1987 Jul; 60(3):44B-47B. PubMed ID: 2956841
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Prevention of restenosis after PTCA--a statistical problem].
    Lechleitner P
    Dtsch Med Wochenschr; 1991 May; 116(22):877. PubMed ID: 2036952
    [No Abstract]   [Full Text] [Related]  

  • 38. Radionuclide techniques in the selection of patients for PTCA and in post-PTCA evaluation.
    Hecht HS
    Cardiol Clin; 1994 May; 12(2):373-83. PubMed ID: 8033183
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Review of antiplatelet drug use in preventing restenosis following percutaneous transluminal coronary angioplasty.
    Cox JL; Gotlieb AI
    Can J Cardiol; 1988 May; 4(4):201-10. PubMed ID: 2456140
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of calcium antagonists on long-term survival of patients treated with coronary angioplasty.
    Kanzaki H; Miyazaki S; Noguchi T; Yasuda S; Sumida H; Daikoku S; Morii I; Itoh A; Goto Y; Nonogi H
    Jpn Heart J; 1999 Jan; 40(1):11-21. PubMed ID: 10370393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.